Citius Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2013 – 2021)

2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-407.40N/A-7.78-4.65-0.21-0.23-0.18-0.43-1.13-0.68-0.22
Price/Sales ratio
N/AN/A7.37K47.87KN/A40.0631.36N/AN/AN/A20.03
Price/Book Value ratio
-869.74-30.46-35.582.300.080.100.110.220.190.191.19
Price/Cash Flow ratio
-620.26N/A-9.47-6.53-0.22-0.26-0.22-0.45-1.08-0.76-0.24
Price/Free Cash Flow ratio
-620.26N/A-9.47-6.53-0.22-0.26-0.22-0.45-0.40-0.31-0.24
Price/Earnings Growth ratio
9.55N/AN/A-0.07-0.000.000.000.01-0.030.02-0.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A100%100%N/AN/A100%N/AN/AN/AN/A
Operating Profit Margin
N/AN/A-105346.67%-924229.65%N/A-18385.52%-17331.51%N/AN/AN/AN/A
Pretax Profit Margin
N/AN/A-94659.75%-1029242.92%N/A-16715.51%17291.27%N/AN/AN/A-8357.75%
Net Profit Margin
N/AN/A-94659.75%-1029242.92%N/A-16715.51%-17291.27%N/AN/AN/AN/A
Effective Tax Rate
N/AN/AN/A10.09%-20.48%-10.11%200.33%-1.01%-2.11%N/A-10.24%
Return on Assets
N/AN/A-391.38%-37.79%-33.97%-40.37%-53.68%-75.21%-16.18%-25.44%-35.88%
Return On Equity
213.48%N/A456.89%-49.47%-37.79%-44.98%-63.83%-52.11%-17.44%-25.29%-43.63%
Return on Capital Employed
191.35%N/A508.47%-44.42%-45.50%-49.48%-63.98%-92.08%-16.99%-26.73%-44.96%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A1.383.151.723.41N/A11.396.39
Quick Ratio
N/A0.670.530.171.383.151.723.4118.2810.760.77
Cash ratio
N/A0.670.490.051.292.881.713.3817.5910.760.67
Days of Sales Outstanding
N/AN/AN/AN/AN/A3.98KN/AN/AN/AN/A1.99K
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A3.98KN/AN/AN/AN/A1.99K
Days of Payables Outstanding
N/AN/AN/AN/AN/A7.65KN/AN/AN/AN/A3.82K
Cash Conversion Cycle
N/AN/AN/AN/AN/A-3.67KN/AN/AN/AN/A-1.83K
Debt Ratios
Debt Ratio
N/A0.38N/A0.060.000.000.000.050.000.080.03
Debt Equity Ratio
-1-0.80N/A0.080.000.000.000.030.000.090.04
Long-term Debt to Capitalization
N/AN/AN/A0.03N/AN/AN/A0.020.000.00N/A
Total Debt to Capitalization
-0.27-4.22N/A0.070.000.000.000.030.000.000.00
Interest Coverage Ratio
N/AN/AN/AN/A-922.35-791.55946.42-1.11KN/A-374.97-648.66
Cash Flow to Debt Ratio
-6.42N/AN/A-4.38-46.08-65.43-71.90-14.25-28.34-38.10-42.09
Company Equity Multiplier
N/A-2.09-1.161.301.111.111.180.691.071.091.11
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-778.02-7.32KN/A-150.90-138.19N/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1N/A111.00111.002.642.441.00
Cash Flow Coverage Ratio
-6.42N/AN/A-4.38-46.08-65.43-71.90-14.25-28.34-38.10-42.09
Short Term Coverage Ratio
-6.42N/AN/A-8.76-46.08-65.43-71.90-51.00-136.82-143.92-55.75
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A